Byrne Asset Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1
| Closed | -$3 | – | 630 |
|
|
2022
Q4 | $3 | Sell |
1
-3,499
| -100% | -$10.5K | ﹤0.01% | 520 |
|
|
2022
Q3 | $130K | Hold |
3,500
| – | – | 0.1% | 137 |
|
|
2022
Q2 | $66K | Sell |
3,500
-3,175
| -48% | -$59.9K | 0.05% | 170 |
|
|
2022
Q1 | $180K | Buy |
6,675
+875
| +15% | +$23.6K | 0.11% | 116 |
|
|
2021
Q4 | $131K | Buy |
+5,800
| New | +$131K | 0.08% | 142 |
|